Browsing Over 32 Presentations
Sort By
CDK4 and CDK6 inhibitors in breast cancer (ID 8)
Educational session
Palbociclib (ID 28)
Lecture Time
13:30 - 13:50
Speakers
- Javier Cortes (Madrid, ES)
Session Name
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
Interaction between CDKs, CDKI and other targets (ID 6)
Educational session
Q&A (ID 22)
Lecture Time
10:40 - 10:50
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Interaction between CDKs, CDKI and other targets (ID 6)
Educational session
Synthetic lethality (ID 17)
Lecture Time
09:00 - 09:20
Speakers
- Rene Bernards (Amsterdam, NL)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Preclinical evidence of efficacy (ID 5)
Educational session
Preclinical evidence of activity of palbociclib (ID 12)
Lecture Time
16:40 - 17:00
Speakers
- Angel Guerrero (Valencia, ES)
Session Name
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Educational session
CDK2 as the bypass kinase for CDK4/6 inhibition (ID 7)
Lecture Time
14:50 - 15:10
Speakers
- Nicholas Turner (London, GB)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
Role of CDK 4-6 inhibitors across solid tumors (ID 9)
Panel Discussion
Panel Discussion (ID 35)
Lecture Time
15:20 - 16:05
Speakers
- Alberto Bardelli (Candiolo, IT)
- Josep Tabernero (Barcelona, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
15:20 - 16:05
CDK4 and CDK6 inhibitors in breast cancer (ID 8)
Educational session
Abemaciclib (ID 30)
Lecture Time
14:10 - 14:30
Speakers
- Antonio Llombart-Cussac (Valencia, ES)
Session Name
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
The disappointing results of initial CDKI and their role in other disease (ID 7)
Educational session
Dinaciclib (ID 24)
Lecture Time
11:10 - 11:35
Speakers
- Cristina Saura (Barcelona, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
11:10 - 12:40
Interaction between CDKs, CDKI and other targets (ID 6)
Educational session
PIK3 (ID 19)
Lecture Time
09:40 - 10:00
Speakers
- Violeta Serra (Barcelona, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Preclinical evidence of efficacy (ID 5)
Educational session
Preclinical evidence of activity of abemaciclib (ID 14)
Lecture Time
17:20 - 17:40
Speakers
- Maria Lallena (Alcobendas, ES)
Session Name
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Educational session
CDK 4-6 inhibition (ID 9)
Lecture Time
14:30 - 14:50
Speakers
- Monica Arnedos (Villejuif, FR)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
The role of CDK along the mitotic process in normal and pathological condition (ID 3)
Educational session
Integration of multiple signalling pathways through control of CDK activation (ID 2)
Lecture Time
13:20 - 13:40
Speakers
- Luca Malorni (Prato, IT)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
13:20 - 14:30